SCHEMBL30206332

SCHEMBL30206332

CNc1nc(Nc2ccc(CN3CCOCC3)nc2)c(C(=O)OC)nc1-c1cncc2c1ncn2C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR3 P22607 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.36
▸ CCNC P24863 2/20 0.35
▸ CDK8 P49336 2/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ EPAS1 Q99814 1/20 0.35
▸ PIK3CA P42336 2/20 0.34
▸ SYK P43405 2/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ LRRK2 Q5S007 2/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ SRC P12931 1/20 0.32
▸ PDGFRA P16234 2/20 0.32
▸ BTK Q06187 1/20 0.32
▸ FLT3 P36888 2/20 0.32
▸ PDE7A Q13946 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29173450 1.00 FGFR3 (0.39) FGFR3HRH3CCNCCDK8HIF1A
SCHEMBL29173651 0.93 HRH3 (0.37) FGFR3HRH3CCNCCDK8HIF1A
SCHEMBL30206281 0.93 HRH3 (0.37) FGFR3HRH3CCNCCDK8HIF1A
SCHEMBL24943841 0.92 SYK (0.38) FGFR3HRH3CCNCCDK8HIF1A
SCHEMBL29173415 0.91 CCNC (0.42) CCNCCDK8SYKLRRK2MAPK1
Formic Acid SCHEMBL29173273 0.89 SYK (0.36) FGFR3HRH3CCNCCDK8HIF1A
Formic Acid SCHEMBL30205745 0.89 SYK (0.36) FGFR3HRH3CCNCCDK8HIF1A
SCHEMBL29173422 0.88 TNIK (0.39) CCNCCDK8SYKSRCPDGFRA
SCHEMBL30206221 0.87 EGFR (0.40) SYKSMN1; SMN2SRC
SCHEMBL30206202 0.86 PKMYT1 (0.40) SYKLRRK2MAPK1SMN1; SMN2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373817-B1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2025-05-21 — — EP disclosed
EP-4373817-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER Astrazeneca AB (SE) 2024-05-29 — — EP disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback